The rapporteur would also like to thank
for their valuable contributions the following non-institutional stakeholders who have communicated their positions and views on the proposed Directive: The European Patients Forum (EPF), the European Organisation for Rare Diseases (EURORODIS), the European Federation of Pharmaceutical Industry Associations (E
FPIA), the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), the European Generic Medicines Association (EGA), GlaxoSmithKline, Celgene, the European Social Insurers Platform
...[+++] (ESIP), the Représentation des institutions françaises de sécurité sociale auprès de l'UE, The Alliance for cost-efficiency in healthcare (COSTEFF), Prescrire and Health Action International - Europe.Außerdem dankt die Berichterstatterin den folgenden nichtinstitutionellen Akteuren, die ihre Stellungnahmen und Ansichten zu der vorgeschlagenen Richtlinie zum Ausdruck gebracht haben, für ihre wertvollen Beiträge: Europäisches Patientenforum (EPF), European Organisation for Rare Diseases (EURORODIS), European Federation of Pharmaceutical Industry Association
s (EFPIA), European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), European Generic Medicines Association (EGA), GlaxoSmithKline, Celgene, European Social Insurance Platform (ESIP),
Représentation des institutions ...[+++] françaises de sécurité sociale auprès de l'UE, Alliance for cost-efficiency in healthcare (COSTEFF), Prescrire und Health Action International - Europe.